Related Experiment Video
Updated: Jun 20, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Hypertensive phase after a novel small-lumen non-valved drainage device: predictive factors and two-year outcomes
Francesc Franquesa-Garcia1,2, Sara Labay-Tejado3, Néstor Ventura-Abreu4
1Department of Ophthalmology, Hospital Germans Trias i Pujol, Carretera de Canyet s/n, 08916, Barcelona, Spain.
Insights
The hypertensive phase after glaucoma drainage device implantation does not affect long-term surgical success. Younger age and elevated early postoperative IOP are risk factors for this phase.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Medical Devices
Background:
- The hypertensive phase (HP) is a common challenge after glaucoma drainage device (GDD) implantation.
- Understanding HP risk factors and its impact on surgical outcomes is crucial for patient management.
Purpose of the Study:
- To evaluate risk factors, clinical features, and the correlation of HP with efficacy in patients receiving a Paul glaucoma implant (PGI).
Main Methods:
- Retrospective cohort study of 83 eyes (71 patients) implanted with PGI.
- Intraocular pressure (IOP) monitored for 2 years postoperatively.
- Analysis of HP occurrence, risk factors, and correlation with success criteria.
Main Results:
- Hypertensive phase observed in 27.7% of cases.
- Younger age and elevated 1-month postoperative IOP identified as independent risk factors.
- Higher IOP in HP group at 1 week and 1-6 months, with no significant difference after 12 months.
Conclusions:
- Hypertensive phase occurrence with PGI does not appear to impact surgical success beyond 12 months.
- Further research is needed to elucidate HP mechanisms and clinical significance.
Purpose:
The hypertensive phase (HP) following the implantation of a glaucoma drainage device (GDD) is a clinical challenge. We aimed to evaluate the risk factors, clinical features, and correlation of the HP with efficacy in a cohort of glaucoma patients who received a Paul glaucoma implant (PGI).
Study Design:
This was a single-center retrospective cohort study (Hospital Clínic of Barcelona).
Methods:
Eighty-three eyes from 71 patients who underwent implantation of a PGI were included, with follow-up extending for up to 2 years. Intraocular pressure (IOP) was measured preoperatively, and at 1 day; 1 week; and 1, 3, 6, 12, and 24 months, postoperatively. Four different success criteria were established: criterion A: IOP <21 mm Hg; criterion B: <18 mm Hg; criterion C: <15 mm Hg; criterion D: <12 mm Hg. The numbers of postoperative IOP-lowering drops, complications, characteristics related to the presence or absence of an HP, and timing of prolene stent removal, among others, were recorded.
Results:
We observed a total of 23 cases (27.7% with an HP). On multivariate analysis we identified younger age (P = .028) and elevated IOP 1 month after surgery (P = .001) as independent risk factors. IOPs were significantly higher (P <.05) in the HP group at 1 week and at 1, 3, and 6 months postoperatively. After 12 months of follow-up, no differences were found between the 2 groups.
Conclusion:
The occurrence of an HP with a PGI does not seem to impact surgical success beyond 12 months postoperatively. However, further research is needed to better understand the underlying mechanisms of HP development and its clinical impact.
Related Concept Videos
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Factors affecting Blood pressure
Physiological Factors:
Assessment of blood pressure in brachial artery(two-step method)
Mitral Regurgitation IV: Nursing Management
Hypertension I: Introduction
Hypertension V: Nursing Management

